Hausa WHO-5 Enters the Conversation on Depression Screening in Nigeria’s Displaced Population
Depression in internally displaced persons is easy to miss and hard to treat. In crowded settings where trauma, separation, poverty, and disrupted care collide, a brief screening tool has real clinical value only if it works in the language people actually use. A validation study in Abuja examined whether the Hausa WHO-5 Well-Being Index could identify probable moderate-to-severe depressive symptoms among internally displaced persons in Nigeria.
The question was practical from the start: can a short, positive-sounding well-being scale perform well enough to function as a depression screen in a population facing intense psychosocial strain? That is not a theoretical exercise. In displacement settings, mental health services are scarce, clinician time is limited, and long questionnaires can fail before they begin.
Psychometric Testing in 264 Internally Displaced Persons
The study enrolled 264 IDPs in Abuja, Nigeria. Each participant completed the Hausa WHO-5 and the PHQ-9, allowing investigators to compare a translated well-being measure against a more familiar depression instrument. The design focused on the core psychometric questions that determine whether a scale is usable at the bedside or in community outreach: internal consistency, factorial structure, construct validity, and screening performance at selected cut points.
Internal consistency was assessed with ordinal Cronbach’s alpha and McDonald’s omega. That choice matters because the WHO-5 is short and ordinal by design; reliability estimates need to match the scale’s structure rather than forcing a crude metric fit. Factorial validity was tested with one-factor confirmatory factor analysis using the weighted least squares mean and variance adjusted estimator, a method suited to ordinal response data. Construct validity was examined through Spearman’s correlation between Hausa WHO-5 and PHQ-9 scores.
One-factor testing is a direct statement about how the instrument behaves clinically. If the items cluster around a single latent dimension, the scale is behaving like a coherent marker of emotional well-being rather than a loose collection of unrelated mood questions.
Why a Brief Well-Being Tool Matters in Displacement Care
In humanitarian settings, screening needs to be fast, comprehensible, and resistant to administration barriers. The Hausa version of the WHO-5 is attractive because it is short and centered on well-being rather than pathology, which may make it easier to deploy in settings where stigma can blunt disclosure. When translated carefully and tested against depressive symptom burden, it can offer a lower-friction entry point into care pathways for people who might never reach a specialty clinic.
A scale like this also fits the realities of task-sharing. Community health workers, non-specialist staff, and outreach teams often do the first pass in displaced populations. If the tool is reliable and valid, it can help flag people who need fuller assessment, psychosocial support, or referral. If it is not, it risks misclassifying distress in a group already carrying a heavy burden.
The burden is not abstract. For IDPs, symptoms often sit at the intersection of trauma exposure, ongoing insecurity, and day-to-day survival needs. Screening tools must therefore do more than translate words; they must preserve meaning across cultural and clinical contexts.
Cut-Point Analysis Aimed at Moderate-to-Severe Symptoms
Receiver operating characteristic analysis was used to assess sensitivity and specificity for cutoffs including ≤28. The study’s endpoint was not merely whether the Hausa WHO-5 correlated with depression scores, but whether it could separate probable moderate-to-severe depressive symptoms from lower-risk states with enough precision to matter in real-world screening.
That distinction is central for humanitarian mental health work. A screen that is psychometrically tidy but clinically blunt adds little value. A screen that is brief, internally consistent, and aligned with symptom burden can help communities move from suspicion to action faster.
Because the excerpt provided here stops before the full set of numerical results, the safest interpretation is limited to the design and intended application of the validation work. The investigators clearly framed the WHO-5 as a potential screening instrument for a displaced Hausa-speaking population, and they built the study around standard psychometric checks that are appropriate for that purpose.
What the Validation Strategy Suggests for Frontline Mental Health Care
The methods used in this study reflect a careful approach to translation and screening science. Correlation with the PHQ-9 offers evidence that the Hausa WHO-5 tracks with depressive symptoms. Internal consistency estimates address whether the items hang together as a scale. Confirmatory factor analysis asks whether the structure of the instrument remains intact after translation. ROC analysis then translates all of that into clinical usability by asking which cut point best separates those likely to have clinically important symptoms from those less likely to do so.
For clinicians working with displaced populations, a validated Hausa WHO-5 could support early identification, especially in settings where formal psychiatric assessment is unavailable or delayed. It would not replace a full diagnostic evaluation, but it could narrow the gap between hidden suffering and first contact with care.
The broader implication is straightforward: screening tools should be judged not only by their statistical elegance but by whether they survive contact with the population they are meant to serve. In a displaced community, language concordance and brevity can determine whether depression is recognized at all.
A Screening Tool Still Needs the Rest of the Care Pathway
Validation is only the first step. Even a strong screening instrument cannot resolve the shortage of mental health services, trauma-focused support, or referral infrastructure that shapes care for internally displaced persons. A useful cutoff can identify need, but it cannot create treatment capacity on its own.
The study therefore sits at an important junction in global mental health: it tests whether a short Hausa-language well-being scale can function as a credible depression screen in Nigerian IDPs, while also exposing the larger service gap that follows any positive result. The key clinical question after screening remains the same—what happens next for the people the tool identifies?